15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 175, Issue 3, Pages 410-418
Publisher
Wiley
Online
2016-07-05
DOI
10.1111/bjh.14241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma
- (2016) Philippe Armand et al. BRITISH JOURNAL OF HAEMATOLOGY
- The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?
- (2016) M. Dreyling et al. HAEMATOLOGICA
- The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?
- (2016) M. Dreyling et al. HAEMATOLOGICA
- miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator
- (2015) S. Husby et al. BLOOD
- High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
- (2015) M.-H. Delfau-Larue et al. BLOOD
- Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
- (2015) Dai Chihara et al. BRITISH JOURNAL OF HAEMATOLOGY
- Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
- (2015) Tadeusz Robak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
- (2015) Jia Ruan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study
- (2014) A. Abrahamsson et al. BLOOD
- Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network
- (2014) Eva Hoster et al. JOURNAL OF CLINICAL ONCOLOGY
- The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma
- (2014) S Robinson et al. LEUKEMIA
- A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213
- (2013) S. H. Bernstein et al. ANNALS OF ONCOLOGY
- Combination of Rituximab, Bendamustine, and Cytarabine for Patients With Mantle-Cell Non-Hodgkin Lymphoma Ineligible for Intensive Regimens or Autologous Transplantation
- (2013) Carlo Visco et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
- (2013) Michael L. Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte
- (2012) R. Delarue et al. BLOOD
- Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
- (2012) Christian H. Geisler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi
- (2011) Francesco Merli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
- (2008) C. H. Geisler et al. BLOOD
- Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
- (2008) Annina Herrmann et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started